{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:44:22Z","timestamp":1776523462204,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,28]]},"DOI":"10.7759\/cureus.23577","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:38:48Z","timestamp":1648489128000},"source":"Crossref","is-referenced-by-count":2,"title":["A Rare Case of Atypical Hemolytic Uremia Syndrome Triggered by Influenza Vaccination"],"prefix":"10.7759","author":[{"given":"Sanjay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Bhagia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kaae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001581","article-title":"A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"70","author":"Besbas N","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, et al.. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006, 70:423-31. 10.1038\/sj.ki.5001581","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050338","article-title":"Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu\/Natal","volume":"11","author":"Bhimma R","year":"1997","unstructured":"Bhimma R, Rollins NC, Coovadia HM, Adhikari M. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu\/Natal. Pediatr Nephrol. 1997, 11:560-4. 10.1007\/s004670050338","journal-title":"Pediatr Nephrol"},{"key":"ref3","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"19","author":"Tarr PI","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005, 19:1073-86.","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta TS","year":"2017","unstructured":"Jokiranta TS. HUS and atypical HUS. Blood. 2017, 129:2847-56. 10.1182\/blood-2016-11-709865","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft198","article-title":"The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome","volume":"28","author":"Szil\u00e1gyi A","year":"2013","unstructured":"Szil\u00e1gyi A, Kiss N, Bereczki C, et al.. The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome. Nephrol Dial Transplant. 2013, 28:2237-45. 10.1093\/ndt\/gft198","journal-title":"Nephrol Dial Transplant"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1690-z","article-title":"Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?","volume":"26","author":"Allen U","year":"2011","unstructured":"Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?. Pediatr Nephrol. 2011, 26:3-5. 10.1007\/s00467-010-1690-z","journal-title":"Pediatr Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song D","year":"2013","unstructured":"Song D, Wu LH, Wang FM, et al.. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013, 15:R12. 10.1186\/ar4142","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S0272-6386(12)80543-9","article-title":"Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome","volume":"20","author":"Hughson MD","year":"1992","unstructured":"Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis. 1992, 20:150-8.","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1258\/om.2011.100059","article-title":"Pregnancy-associated atypical haemolytic uraemic syndrome in the postpartum period: a case report and review of the literature","volume":"4","author":"Egbor M","year":"2011","unstructured":"Egbor M, Johnson A, Harris F, Makanjoula D, Shehata H. Pregnancy-associated atypical haemolytic uraemic syndrome in the postpartum period: a case report and review of the literature. Obstet Med. 2011, 4:83-5. 10.1258\/om.2011.100059","journal-title":"Obstet Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182603598","article-title":"Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases","volume":"91","author":"Lechner K","year":"2012","unstructured":"Lechner K, Obermeier HL. Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore). 2012, 91:195-205. 10.1097\/MD.0b013e3182603598","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"Morton JM","year":"2016","unstructured":"Morton JM, George JN. Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer. J Oncol Pract. 2016, 12:523-30. 10.1200\/JOP.2016.012096","journal-title":"J Oncol Pract"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1016\/j.transproceed.2012.07.039","article-title":"De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival","volume":"44","author":"Caires RA","year":"2012","unstructured":"Caires RA, Marques ID, Repizo LP, et al.. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival. Transplant Proc. 2012, 44:2388-90.","journal-title":"Transplant Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris M","year":"2010","unstructured":"Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transplant. 2010, 10:1517-23. 10.1111\/j.1600-6143.2010.03156.x","journal-title":"Am J Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.87","article-title":"Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy","volume":"51","author":"Vasu S","year":"2016","unstructured":"Vasu S, Wu H, Satoskar A, et al.. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant. 2016, 51:1241-4. 10.1038\/bmt.2016.87","journal-title":"Bone Marrow Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri ZL","year":"2015","unstructured":"Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015, 125:616-8. 10.1182\/blood-2014-11-611335","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft078","article-title":"Eculizumab and drug-induced haemolytic-uraemic syndrome","volume":"6","author":"Faguer S","year":"2013","unstructured":"Faguer S, Huart A, Fr\u00e9meaux-Bacchi V, Ribes D, Chauveau D. Eculizumab and drug-induced haemolytic-uraemic syndrome. Clin Kidney J. 2013, 6:484-5. 10.1093\/ckj\/sft078","journal-title":"Clin Kidney J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat C","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, et al.. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2016, 31:15-39. 10.1007\/s00467-015-3076-8","journal-title":"Pediatr Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester CM","year":"2015","unstructured":"Nester CM, Barbour T, de Cordoba SR, et al.. Atypical aHUS: state of the art. Mol Immunol. 2015, 67:31-42. 10.1016\/j.molimm.2015.03.246","journal-title":"Mol Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1983.tb18116.x","article-title":"Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3","volume":"421","author":"Pangburn MK","year":"1983","unstructured":"Pangburn MK, M\u00fcller-Eberhard HJ. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3. Ann N Y Acad Sci. 1983, 421:291-8. 10.1111\/j.1749-6632.1983.tb18116.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7194","article-title":"Covalent binding and hemolytic activity of complement proteins","volume":"77","author":"Law SK","year":"1980","unstructured":"Law SK, Lichtenberg NA, Levine RP. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci U S A. 1980, 77:7194-8. 10.1073\/pnas.77.12.7194","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083170","article-title":"Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes","volume":"110","author":"Ferreira VP","year":"2007","unstructured":"Ferreira VP, Pangburn MK. Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood. 2007, 110:2190-2. 10.1182\/blood-2007-04-083170","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel PF","year":"2009","unstructured":"Zipfel PF, Skerka C. Complement regulators and inhibitory proteins. Nat Rev Immunol. 2009, 9:729-40. 10.1038\/nri2620","journal-title":"Nat Rev Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2010.173","article-title":"Dynamic control of the complement system by modulated expression of regulatory proteins","volume":"91","author":"Thurman JM","year":"2011","unstructured":"Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest. 2011, 91:4-11. 10.1038\/labinvest.2010.173","journal-title":"Lab Invest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen MJ","year":"2009","unstructured":"Lehtinen MJ, Rops AL, Isenman DE, van der Vlag J, Jokiranta TS. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome. J Biol Chem. 2009, 284:15650-8. 10.1074\/jbc.M900814200","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian T","year":"2003","unstructured":"Manuelian T, Hellwage J, Meri S, et al.. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest. 2003, 111:1181-90. 10.1172\/JCI16651","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh D","year":"2005","unstructured":"Kavanagh D, Kemp EJ, Mayland E, et al.. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005, 16:2150-5. 10.1681\/ASN.2005010103","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-015-0029-z","article-title":"Complement regulator CD46: genetic variants and disease associations","volume":"9","author":"Liszewski MK","year":"2015","unstructured":"Liszewski MK, Atkinson JP. Complement regulator CD46: genetic variants and disease associations. Hum Genomics. 2015, 9:7. 10.1186\/s40246-015-0029-z","journal-title":"Hum Genomics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome","volume":"182","author":"Ferreira VP","year":"2009","unstructured":"Ferreira VP, Herbert AP, Cort\u00e9s C, et al.. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. J Immunol. 2009, 182:7009-18. 10.4049\/jimmunol.0804031","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey MA","year":"2005","unstructured":"Dragon-Durey MA, Loirat C, Cloarec S, et al.. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2005, 16:555-63. 10.1681\/ASN.2004050380","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1415-3","article-title":"A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome","volume":"25","author":"Tawadrous H","year":"2010","unstructured":"Tawadrous H, Maga T, Sharma J, Kupferman J, Smith RJ, Schoeneman M. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome. Pediatr Nephrol. 2010, 25:947-51. 10.1007\/s00467-009-1415-3","journal-title":"Pediatr Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome","volume":"114","author":"Roumenina LT","year":"2009","unstructured":"Roumenina LT, Jablonski M, Hue C, et al.. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood. 2009, 114:2837-45. 10.1182\/blood-2009-01-197640","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-1039-4","article-title":"Clinical practice. Today's understanding of the haemolytic uraemic syndrome","volume":"169","author":"Scheiring J","year":"2010","unstructured":"Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr. 2010, 169:7-13. 10.1007\/s00431-009-1039-4","journal-title":"Eur J Pediatr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1854-x","article-title":"Renal complications of seasonal and pandemic influenza A virus infections","volume":"172","author":"Watanabe T","year":"2013","unstructured":"Watanabe T. Renal complications of seasonal and pandemic influenza A virus infections. Eur J Pediatr. 2013, 172:15-22. 10.1007\/s00431-012-1854-x","journal-title":"Eur J Pediatr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori M","year":"2013","unstructured":"Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol. 2013, 2:56-76. 10.5527\/wjn.v2.i3.56","journal-title":"World J Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris M","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009, 361:1676-87. 10.1056\/NEJMra0902814","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-18603-0_3","article-title":"Role of complement on broken surfaces after trauma","volume":"865","author":"Huber-Lang M","year":"2015","unstructured":"Huber-Lang M, Ignatius A, Brenner RE. Role of complement on broken surfaces after trauma. Adv Exp Med Biol. 2015, 865:43-55. 10.1007\/978-3-319-18603-0_3","journal-title":"Adv Exp Med Biol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0512-y","article-title":"Case report - atypical hemolytic uremic syndrome triggered by influenza B","volume":"18","author":"Kobbe R","year":"2017","unstructured":"Kobbe R, Schild R, Christner M, Oh J, Loos S, Kemper MJ. Case report - atypical hemolytic uremic syndrome triggered by influenza B. BMC Nephrol. 2017, 18:96. 10.1186\/s12882-017-0512-y","journal-title":"BMC Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-017-2856-5","article-title":"Occurrence of atypical HUS associated with influenza B","volume":"176","author":"van Hoeve K","year":"2017","unstructured":"van Hoeve K, Vandermeulen C, Van Ranst M, Levtchenko E, van den Heuvel L, Mekahli D. Occurrence of atypical HUS associated with influenza B. Eur J Pediatr. 2017, 176:449-54. 10.1007\/s00431-017-2856-5","journal-title":"Eur J Pediatr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-1081-2","article-title":"Streptococcus pneumoniae-associated haemolytic uremic  syndrome following influenza A virus infection","volume":"169","author":"Lei TH","year":"2010","unstructured":"Lei TH, Hsia SH, Wu CT, Lin JJ. Streptococcus pneumoniae-associated haemolytic uremic  syndrome following influenza A virus infection. Eur J Pediatr. 2010, 169:237-9. 10.1007\/s00431-009-1081-2","journal-title":"Eur J Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32835d7f2c","article-title":"Update on Streptococcus pneumoniae associated hemolytic uremic syndrome","volume":"25","author":"Spinale JM","year":"2013","unstructured":"Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L. Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr. 2013, 25:203-8. 10.1097\/MOP.0b013e32835d7f2c","journal-title":"Curr Opin Pediatr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1603-1","article-title":"Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome","volume":"26","author":"Printza N","year":"2011","unstructured":"Printza N, Roilides E, Kotsiou M, Zafeiriou D, Hatzidimitriou V, Papachristou F. Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome. Pediatr Nephrol. 2011, 26:143-4. 10.1007\/s00467-010-1603-1","journal-title":"Pediatr Nephrol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.10.1516","article-title":"Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea","volume":"31","author":"Cheong HI","year":"2016","unstructured":"Cheong HI, Jo SK, Yoon SS, et al.. Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea. J Korean Med Sci. 2016, 31:1516-28. 10.3346\/jkms.2016.31.10.1516","journal-title":"J Korean Med Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell R","year":"2015","unstructured":"Cofiell R, Kukreja A, Bedard K, et al.. Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood. 2015, 125:3253-62. 10.1182\/blood-2014-09-600411","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-516237","article-title":"How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome","volume":"123","author":"Cataland SR","year":"2014","unstructured":"Cataland SR, Wu HM. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome. Blood. 2014, 123:2478-84. 10.1182\/blood-2013-11-516237","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/90903-a-rare-case-of-atypical-hemolytic-uremia-syndrome-triggered-by-influenza-vaccination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:18Z","timestamp":1707507678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/90903-a-rare-case-of-atypical-hemolytic-uremia-syndrome-triggered-by-influenza-vaccination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.23577","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}